Muscle cell membrane stabilization

“Muscle cell membrane stabilization” is not a discrete molecular target, receptor, enzyme, or protein, but rather describes a broad process involving multiple endogenous pathways and exogenous agents that enhance the integrity and repair of the sarcolemma (muscle cell membrane), especially under stress or injury. Central proteins involved in endogenous membrane repair include dysferlin (mediates vesicle fusion for repair) and thrombospondin 4 (enhances trafficking and chaperoning of the dystrophin-glycoprotein complex and integrins to the membrane), with loss of these pathways leading to membrane weakness[1]. Pharmacologic agents like Poloxamer 188 (P188), a triblock copolymer, have demonstrated direct physical interaction with damaged muscle membranes, stabilizing and preventing further injury in preclinical models of muscular dystrophy and membrane-damaging conditions[2]. In vascular smooth muscle, high concentrations of calcium show a membrane-stabilizing effect, believed to function via activation of sodium-potassium ATPase[3]. “Muscle cell membrane stabilization” therefore refers to a therapeutic strategy and mechanism of action, but not a canonical single molecule or receptor.

Other names

Muscle membrane stabilizationSarcolemma stabilization

Physical stabilization of membrane bilayer (P188/copolymers), Enhancement of membrane repair via endogenous repair proteins (e.g., dysferlin, thrombospondin 4), Calcium-induced sodium-potassium ATPase activation in vascular smooth muscle